Subscribe to Our Newsletter!

A quick summary of the life science industry investor news in 2022, and what the future holds for MedTech and biotech companies in 2023! Catch up on industry news in Kevin's newsletter.

Learn the latest news on the Theranos/Elizabeth Holmes trial that has captivated the public interest this year. learn what drug costs an arm and a leg and the status of life science companies scaling back - all in Kevin's newsletter.

Read Kevin Coker's latest newsletter about companies and technologies getting ready to ride out the turbulence of the life science industry.

Are you following the latest biotech industry investment news? Learn the latest news in the life sciences industry investment and how close a (complex) human heart structure is to being built from our CEO, Kevin Coker.

Are you following the latest biotech industry investment news? Learn the latest news in the life sciences industry investment and how close a (complex) human heart structure is to being built from our CEO, Kevin Coker.

Did you know Google's artificial intelligence (AI), named LaMDA, hired a lawyer? Learn the latest news in the life sciences industry investment and why the unicorn companies will save us from our CEO, Kevin Coker.

Do you know why a “checkpoint inhibitor” is important for learning oncology developments? Learn the latest news in the life sciences industry such as why FemTech is a hot market right now and why crime doesn't pay from our CEO, Kevin Coker.

Have you heard about J&J "two steps" back on trial? Learn the latest news in the life sciences industry for drugs, MedTech, diagnostics, vaccines, and therapeutics analyzed by our CEO, Kevin Coker.

Have you heard about the life sciences bubble? Our industry has been vastly inflated due to record-setting fundraising combined with the pursuit of Covid products, namely diagnostics, vaccines, and therapeutics. Learn more from Kevin Coker.